Hemochromatosis gene mutations in chronic hepatitis “C” patients

被引:0
|
作者
Ibrahim N.S. [1 ]
Menesy M. [2 ]
机构
[1] Department of Clinical and Chemical Pathology, El-Kasr El-Aini Hospital, Cairo University, El-Manial, Cairo
[2] Department of Internal Medicine, El-Kasr El-Aini Hospital, Cairo University, El-Manial, Cairo
关键词
Ferritin; Hemochromatosis; Hepatitis C; HFE; Iron;
D O I
10.1007/s00580-015-2193-x
中图分类号
学科分类号
摘要
Hepatitis C virus (HCV) infection is a significant global health problem. Elevated hepatic iron concentration has often been found in patients with chronic hepatitis C, and this excess iron increases oxidative stress, which can accelerate the progression of fibrosis and may promote hepatic carcinogenesis. The current study aimed to determine the prevalence of C282Y (exchange of cysteine to tyrosine at amino acid 282) and H63D (exchange of histidine to aspartic acid at amino acid 63) in hereditary hemochromatosis gene (HFE) mutations among chronic HCV patients and to find whether elevation of serum iron indices is related to HFE gene mutations in patients with chronic hepatitis C. The study population was 80 chronic HCV patients divided into two groups: group I included 40 patients with serum iron overload, and group II included 40 patients without iron overload. HFE gene mutation was studied by PCR-restriction fragment length polymorphism (RFLP). The C282Y mutation was not found in any of the 80 patients, while the H63D mutation was present in 18.7 % of the entire study sample. Comparing the two studied groups, H63D mutation was found in 20 % of the iron overload group and 17.5 % of the non-iron overload group. Statistically, there was no significant difference between the two study groups. Regarding iron studies, results of the current study revealed no significant difference between chronic HCV patients with iron overload and those with normal iron profile regarding any of the HFE mutations. In conclusion, the current work emphasizes that the C282Y mutation is absent in our community, while H63D mutation presence does not differ greatly from other Caucasian races especially in Europe. The current study did not detect any effect of HFE mutation on increasing serum iron overload. © 2015, Springer-Verlag London.
引用
收藏
页码:375 / 380
页数:5
相关论文
共 50 条
  • [41] Correlation of hemochromatosis gene mutations and cardiovascular disease in hemodialysis patients
    Bi, Min
    Li, Bing
    Li, Qiang
    ANNALS OF SAUDI MEDICINE, 2013, 33 (03) : 223 - 228
  • [42] Distribution of HFE gene mutations in Slovenian patients with hereditary hemochromatosis
    Stepec, Srecko
    Makuc, Jana
    Markovic, Sasa
    Medica, Igor
    Peterlin, Borut
    ANNALS OF HEMATOLOGY, 2008, 87 (08) : 667 - 669
  • [43] Distribution of HFE gene mutations in Slovenian patients with hereditary hemochromatosis
    Srecko Stepec
    Jana Makuc
    Sasa Markovic
    Igor Medica
    Borut Peterlin
    Annals of Hematology, 2008, 87 : 667 - 669
  • [44] Mutations in the S gene of hepatitis B virus in three generations of patients with chronic hepatitis B
    Malihe Naderi
    Seyed Masoud Hosseini
    Naser Behnampour
    Iraj Shahramian
    Abdolvahab Moradi
    Virus Genes, 2023, 59 : 662 - 669
  • [45] Mutations in the S gene of hepatitis B virus in three generations of patients with chronic hepatitis B
    Naderi, Malihe
    Hosseini, Seyed Masoud
    Behnampour, Naser
    Shahramian, Iraj
    Moradi, Abdolvahab
    VIRUS GENES, 2023, 59 (05) : 662 - 669
  • [46] Prevalence of HFE (hemochromatosis) gene mutations in patients with cluster headache
    Rainero, I
    Rivoiro, C
    Rubino, E
    Milli, V
    Valfrè, W
    De Martino, P
    Lo Giudice, R
    Angilella, G
    Savi, L
    Gallone, S
    Pinessi, L
    HEADACHE, 2005, 45 (09): : 1219 - 1223
  • [47] Increased prevalence of the hemochromatosis gene mutations in patients with hepatocellular carcinoma
    Aldersley, MA
    Komolmit, P
    Hamlin, PJ
    Markham, AF
    Wyatt, JI
    Robinson, PA
    Howdle, PD
    GASTROENTEROLOGY, 1999, 116 (04) : A1182 - A1182
  • [48] Influence of haemochromatosis gene mutations on treatment outcomes in patients with hepatitis C
    Chapman, BA
    Burt, MJ
    Frampton, CMA
    Chapman, TM
    Whitehead, MR
    Upton, JD
    George, PM
    INTERNAL MEDICINE JOURNAL, 2001, 31 (04) : 254 - 255
  • [49] Mutations in the nonstructural protein 5A gene in chronic hepatitis C virus in infection patients with interferon treatment
    Niiyama, G
    Kimura, T
    Mitani, K
    Tsugeno, H
    Sengoku, N
    Kinoyama, S
    Ito, T
    Kinoshita, M
    Yamada, G
    HEPATOLOGY, 1996, 24 (04) : 150 - 150
  • [50] Patients with Chronic Hepatitis C May be More Sensitive to Iron Hepatotoxicity than Patients with HFE-Hemochromatosis
    Hayashi, Hisao
    Piperno, Alberto
    Tomosugi, Naohisa
    Hayashi, Kazuhiko
    Kimura, Fumiaki
    Wakusawa, Shinya
    Yano, Motoyoshi
    Tatsumi, Yasuaki
    Hattori, Ai
    Pelucchi, Sara
    Katano, Yoshiaki
    Goto, Hidemi
    INTERNAL MEDICINE, 2010, 49 (22) : 2371 - 2377